Castleman's disease CT

Castleman's disease Microchapters
Home
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Castleman's disease from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Castleman's disease CT On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Castleman's disease CT All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Castleman's disease CT
CDC on Castleman's disease CT
Castleman's disease CT in the news
Blogs on Castleman's disease CT
Directions to Hospitals Treating Castleman's disease
Risk calculators and risk factors for Castleman's disease CT

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]

CT Scan

• To detect the enlarged lymph nodes in the chest, neck, abdomen, groin.
• Enlargement of liver and spleen can also be detected.
• Findings include:
  • Contrast enhancement
  • Homogenous

(A)Castleman's disease Preoperative CT scan of the abdomen showing a highly vascularized retroperitoneal tumor measuring 10 × 9.2 cm with intratumor calcifications. Right ureter dilatation (grade II), (coronal multiplanar reformation, MPR) (B) The same tumor in axial orientation. No other tumor localization in the abdomen nor enlarged lymph nodes were detected.